175 related articles for article (PubMed ID: 31253857)
1. Elevated numbers of PD-L1 expressing B cells are associated with the development of AIDS-NHL.
Epeldegui M; Conti DV; Guo Y; Cozen W; Penichet ML; Martínez-Maza O
Sci Rep; 2019 Jun; 9(1):9371. PubMed ID: 31253857
[TBL] [Abstract][Full Text] [Related]
2. Extracellular vesicles as biomarkers for AIDS-associated non-Hodgkin lymphoma risk.
Martínez LE; Magpantay LI; Guo Y; Hegde P; Detels R; Hussain SK; Epeldegui M
Front Immunol; 2023; 14():1259007. PubMed ID: 37809067
[TBL] [Abstract][Full Text] [Related]
3. TLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosis.
Guo Y; Siewe B; Epeldegui M; Detels R; Landay AL; Martínez-Maza O
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):204-10. PubMed ID: 23722608
[TBL] [Abstract][Full Text] [Related]
4. Plasma extracellular vesicles bearing PD-L1, CD40, CD40L or TNF-RII are significantly reduced after treatment of AIDS-NHL.
Martínez LE; Lensing S; Chang D; Magpantay LI; Mitsuyasu R; Ambinder RF; Sparano JA; Martínez-Maza O; Epeldegui M
Sci Rep; 2022 Jun; 12(1):9185. PubMed ID: 35655072
[TBL] [Abstract][Full Text] [Related]
5. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.
Breen EC; Hussain SK; Magpantay L; Jacobson LP; Detels R; Rabkin CS; Kaslow RA; Variakojis D; Bream JH; Rinaldo CR; Ambinder RF; Martinez-Maza O
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1303-14. PubMed ID: 21527584
[TBL] [Abstract][Full Text] [Related]
6. PD-L1
Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
Front Immunol; 2018; 9():2241. PubMed ID: 30327652
[No Abstract] [Full Text] [Related]
7. CD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes.
Epeldegui M; Thapa DR; De la Cruz J; Kitchen S; Zack JA; Martínez-Maza O
PLoS One; 2010 Jul; 5(7):e11448. PubMed ID: 20625427
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death-ligand 1 (PD-L1) axis in post-transplant lymphoproliferative disorders: association with Epstein-Barr virus, PD-L1 copy number alterations, and outcome.
Veloza L; Teixido C; Castrejon N; Climent F; Carrió A; Marginet M; Soldini D; González-Farré B; Ribera-Cortada I; Lopez-Guillermo A; González-Barca E; Sierra A; Herrera M; Gómez C; Garcia A; Balagué O; Campo E; Martinez A
Histopathology; 2019 Dec; 75(6):799-812. PubMed ID: 30861172
[TBL] [Abstract][Full Text] [Related]
9. Direct Epstein-Barr virus (EBV) typing on peripheral blood mononuclear cells: no association between EBV type 2 infection or superinfection and the development of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma.
van Baarle D; Hovenkamp E; Kersten MJ; Klein MR; Miedema F; van Oers MH
Blood; 1999 Jun; 93(11):3949-55. PubMed ID: 10339504
[TBL] [Abstract][Full Text] [Related]
10. Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance.
Fisher KE; Ferguson LS; Coffey AM; Merritt BY; Curry JL; Marcogliese AN; Major AM; Kamdar KY; Lopez-Terrada DH; Curry CV
Haematologica; 2022 Aug; 107(8):1880-1890. PubMed ID: 35081690
[TBL] [Abstract][Full Text] [Related]
11. The Role of Microbial Translocation and Immune Activation in AIDS-Associated Non-Hodgkin Lymphoma Pathogenesis: What Have We Learned?
Epeldegui M; Hussain SK
Crit Rev Immunol; 2020; 40(1):41-51. PubMed ID: 32421978
[TBL] [Abstract][Full Text] [Related]
12. Follicular CD8+ T Cells Are Elevated in HIV Infection and Induce PD-L1 on B Cells.
Martínez LE; Ibarrondo J; Guo Y; Penichet ML; Epeldegui M
J Immunol; 2023 Jan; 210(1):33-39. PubMed ID: 36445393
[TBL] [Abstract][Full Text] [Related]
13. Immune Activation: Contribution to AIDS-Associated Non-Hodgkin Lymphoma.
Epeldegui M; Martínez-Maza O
For Immunopathol Dis Therap; 2015; 6(1-2):79-90. PubMed ID: 28702272
[TBL] [Abstract][Full Text] [Related]
14. Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma.
Piriou E; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
Blood; 2005 Nov; 106(9):3166-74. PubMed ID: 16014568
[TBL] [Abstract][Full Text] [Related]
15. Programmed cell death-ligand 1 (PD-L1)
Kimura S; Oshiro Y; Iwasaki H; Kadowaki M; Mihashi Y; Sakata T; Kawauchi S; Wang Z; Takamatsu Y; Takeshita M
Clin Exp Med; 2022 Aug; 22(3):411-419. PubMed ID: 34515880
[TBL] [Abstract][Full Text] [Related]
16. Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells.
Andorsky DJ; Yamada RE; Said J; Pinkus GS; Betting DJ; Timmerman JM
Clin Cancer Res; 2011 Jul; 17(13):4232-44. PubMed ID: 21540239
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 mediated the differentiation of tumor-infiltrating CD19
Guan H; Lan Y; Wan Y; Wang Q; Wang C; Xu L; Chen Y; Liu W; Zhang X; Li Y; Gu Y; Wang Z; Xie F
Oncoimmunology; 2016 Feb; 5(2):e1075112. PubMed ID: 27057444
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME
J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591
[TBL] [Abstract][Full Text] [Related]
19. Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study.
Wong HL; Breen EC; Pfeiffer RM; Aissani B; Martinson JJ; Margolick JB; Kaslow RA; Jacobson LP; Ambinder RF; Chanock S; Martínez-Maza O; Rabkin CS
AIDS; 2010 Apr; 24(7):1025-33. PubMed ID: 20299965
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 Is Involved in the Development of Non-Hodgkin's Lymphoma by Mediating Circulating Lymphocyte Apoptosis.
Saber MM
Vaccines (Basel); 2023 Sep; 11(9):. PubMed ID: 37766150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
